NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002068

Registered date:11/06/2009

Effectiveness of rebamipide for human gastric membrane after distal gastrectomy

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedGastritis in remnant stomach
Date of first enrollment2009/05/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Rebamipide 300mg per day for a year No treatment

Outcome(s)

Primary OutcomePatient number with gastritis or inflammatory change in remnant stomach
Secondary OutcomeLoss of body weight

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteria1.Patients treated with gastric secretion inhibitor in a month prior to this study. 2.Patients with thoracotomy, hepatectomy, pancreatomy or colectomy. 3.Patients with other malignancy. 4.Patients with cardiac, hepatic or hematologic disease.

Related Information

Contact

public contact
Name Hiroshi Kawahira
Address 1-8-1, Inohana, Chuouku,Chiba Japan
Telephone 043-222-7171
E-mail hk@faculty.chiba-u.jp
Affiliation Chiba University Graduate School of Medicine Frontier Surgery
scientific contact
Name Hisahiro Matsubara
Address 1-8-1, Inohana, Chuouku,Chiba Japan
Telephone 043-222-7171
E-mail hk@faculty.chiba-u.jp
Affiliation Chiba University Graduate School of Medicine Frontier Surgery